LEGEND BIOTECH CORP (LEGN)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · LEGN
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
No current thesis-health read is available for this company.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -63.2% |
| Our one-year growth estimate | diamond | Not available |
Growth built into the price is above our model estimate.
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-09-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
A larger daily loss that occurred about once in every 20 trading days.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A comparable growth gap is not available.
The one-year revenue growth assumption on Valuation.
Model as of 2026-09-04 · Compared with 398 industry peers · Company calendar date is not available
Why it matters: Revenue growth trends can signal the health of the business. A drop below median may raise concerns.
Worry ifRevenue growth falls below the median growth rate for the sector.
Less concerning ifRevenue growth remains above the median growth rate for the sector.
Why it matters: The earnings report will show how the company is doing. It will also hint at future plans.
Watch forThe earnings report shows revenue and profit growth that is better than expected.
Also watch forThe earnings report shows revenue and profit growth that is worse than expected.
Why it matters: If revenue growth speeds up, it shows health in the sector. This could boost investor confidence in Legend Biotech.
Supportive ifThree-year revenue growth in the healthcare sector rises back toward 12% or higher.
Worry ifThree-year revenue growth in the healthcare sector stays below 9%.
Why it matters: Earnings results will show how well Legend Biotech is performing. Strong results could boost confidence.
Supportive ifEarnings per share (EPS) beats analyst expectations by more than 10%.
Worry ifEPS falls short of analyst expectations by more than 10%.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$209 on $10,000 · ±2.1% | How much price usually moves either way. |
| Bad day | $611 loss on $10,000 · 6.1% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $5,385 loss on $10,000 · 53.8% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: If peers like Lilly and AbbVie continue to excel, it could pressure Legend's market position.
Worry ifLilly or AbbVie announce a big drug approval or a revenue rise.
Less concerning ifPeers report setbacks in drug approvals or declining revenue.
Why it matters: This index affects costs for healthcare companies like Legend Biotech.
Watch forPPI increases more than 0.5% month over month, indicating rising costs.
Also watch forPPI decreases or remains flat, suggesting stable or declining costs.
Why it matters: CPI affects inflation and can change how much is spent on healthcare.
Watch forCPI goes above 0.4% month over month. This shows higher inflation.
Also watch forCPI falls or stays below 0.2%, indicating lower inflation.
Why it matters: Interest rate changes can affect funding costs and investment in biotech.
Watch forFOMC raises rates. This shows a tighter monetary policy.
Also watch forFOMC keeps rates the same or lowers them. This shows a looser policy.